BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 9489453)

  • 1. [Immunopathology of Graves'-Basedow disease].
    Baj Z; Ferenc T; Lewiński A
    Postepy Hig Med Dosw; 1997; 51(5):531-46. PubMed ID: 9489453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiopathogenesis of Graves' disease.
    Karasek M; Lewinski A
    Neuro Endocrinol Lett; 2003; 24(3-4):161-6. PubMed ID: 14523350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of antigen receptor variable region repertoires in T lymphocytes infiltrating the intrathyroidal and extrathyroidal manifestations in patients with Graves' disease.
    Heufelder AE; Schworm HD; Wenzel BE; Garrity JA; Bahn RS
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():84-7. PubMed ID: 8981009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen receptor variable region repertoires expressed by T cells infiltrating thyroid, retroorbital, and pretibial tissue in Graves' disease.
    Heufelder AE; Wenzel BE; Scriba PC
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3733-9. PubMed ID: 8855831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' disease: xenotransplantation model (athymic nude mice).
    Jungheim K; Schumm-Draeger PM; Usadel KH
    J Mol Med (Berl); 1999 Jan; 77(1):185-8. PubMed ID: 9930960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Basedow-Graves disease development in 2 patients with primary hypothyroidism: exceptional development of the autoimmune thyroid disease].
    Arteaga E; Campusano C; Michaud P
    Rev Med Chil; 1993 Nov; 121(11):1300-4. PubMed ID: 8191138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two sisters, one with Graves' disease and the second with thyroiditis and transient hyperthyroidism.
    Tong A; Farid NR; Stenszky V
    Acta Med Acad Sci Hung; 1982; 39(1-2):7-10. PubMed ID: 6897475
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of thyroidal and extrathyroidal thyrotropin receptors.
    Hoermann R
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():88-91. PubMed ID: 8981010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid-associated eye disease.
    Heufelder AE; Joba W
    Strabismus; 2000 Jun; 8(2):101-11. PubMed ID: 10980691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex investigation of Graves'-Basedow disease: case report.
    Luca IC; Bene MC; Cotuţiu C
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):202-4. PubMed ID: 10756799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and classification of Graves' disease.
    Menconi F; Marcocci C; Marinò M
    Autoimmun Rev; 2014; 13(4-5):398-402. PubMed ID: 24424182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a transgenic animal model of hyperthyroid Graves' disease.
    Kim-Saijo M; Akamizu T; Ikuta K; Iida Y; Ohmori K; Matsubara K; Matsuda Y; Suzuki M; Matsuda F; Nakao K
    Eur J Immunol; 2003 Sep; 33(9):2531-8. PubMed ID: 12938229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
    Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
    J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancer yield in patients with Graves' disease.
    Stocker DJ; Burch HB
    Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves' ophthalmopathy.
    Burch HB; Sellitti D; Barnes SG; Nagy EV; Bahn RS; Burman KD
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1384-91. PubMed ID: 8200941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSH receptor protein is selectively expressed in normal human extraocular muscle.
    Kloprogge SJ; Busuttil BE; Frauman AG
    Muscle Nerve; 2005 Jul; 32(1):95-8. PubMed ID: 15779008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.